Progyny (PGNY) News
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
35.71+0.26 (+0.73%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PGNY news summary
We found 17 recent headlines mentioning Progyny (PGNY): 1 in the past week and 9 in the past 30 days, most often from Nasdaq, GlobeNewswire, Investor's Business Daily. For price context, PGNY is up 0.73% at $35.71. The most recent story, "5 Relative Price Strength Stocks to Tap Amid S&P 500 Weakness", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Progyny headlines
- 5 Relative Price Strength Stocks to Tap Amid S&P 500 WeaknessPGNY, WWW, TDC, NUE and COP offer investors a way to tap relative price strength amid market volatility, backed by solid fundamentals and upbeat earnings prospects.NasdaqCOP, NUE, TDC, WWW
- Progyny: 3 Key Takeaways for Long-Term InvestorsKey PointsProgyny added 1.3 million covered lives for the 2027 plan year.NasdaqPGNY, BIO.B
- Fertility Treatment Leader Progyny Breaks Out Past Buy Point As Earnings Surge 113%Progyny stock broke out past its latest buy point after the company's Q3 earnings surged 113% vs. year-ago period. The post Fertility Treatment Leader Progyny Breaks Out Past Buy Point As Earnings…Investor's Business Daily
- Progyny Reaches Analyst Target PriceIn recent trading, shares of Progyny Inc (Symbol: PGNY) have crossed above the average analyst 12-month target price of $34.00, changing hands for $34.37/share. When a stock reaches the target an…NasdaqPGNY, HEI.A
- Progyny (PGNY) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Progyny raises 2026 revenue outlook to $1.365B-$1.385B as it adds 1.3 million new covered livesSeeking Alpha
- Progyny, Inc. Announces Third Quarter 2026 ResultsReports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income Selling Season Yields Record 1.3 Million New Covered Lives with Another Year of Near 100% Retention…GlobeNewswire
- New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to BenefitsResearch presented at ASRM 2026 Scientific Congress & Expo highlights the importance of early engagement and personalized support in helping patients navigate fertility care Research presented at…GlobeNewswire
- New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care ModelNew Progyny research finds more than 70% of members studied reported menopause symptom improvement, highlighting the value of connected care.GlobeNewswire
- Progyny, Inc. Announces Details for Its Third Quarter 2026 Results ReportNEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period…GlobeNewswire
- Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="left">NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <a href="htt…Business Insider
- Progyny to Present New Menopause Research at The Menopause Society 2026 Annual MeetingNEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating…GlobeNewswire
- Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?Progyny (PGNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in…NasdaqPGNY, AVTR
- PGNY or CRL: Which Is the Better Value Stock Right Now?PGNY vs. CRL: Which Stock Is the Better Value Option?NasdaqPGNY, CRL
- PGNY vs. CRL: Which Stock Is the Better Value Option?PGNY vs. CRL: Which Stock Is the Better Value Option?NasdaqPGNY, CRL
- Bet on These 4 Top-Performing Liquid Stocks to Maximize ReturnsMNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.NasdaqWK, MTCH, PGNY, MNDY
- MTD Second Quarter Earnings Beat Estimates on China-Led Sales GrowthMTD beats Q2 earnings estimates as strong China and emerging-market sales fuel growth, while the company raises its 2026 sales and earnings outlook.NasdaqMTD, CNC, PGNY